AIM
BIIB icon

Advyzon Investment Management’s Biogen BIIB Stock Holding History

Advyzon Investment Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$216K Sell
1,000
-129
-11% -$24.7K 0.02% 717
2026
Q1 		$207K Sell
1,129
-83
-7% -$15.3K 0.02% 648
2025
Q4 		$213K Buy
+1,212
New +$198K 0.02% 553

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Advyzon Investment Management's BIIB Position: Q2 2026 in Review

Advyzon Investment Management reduced its Biogen (BIIB) stake by 11% in Q2 2026, selling an estimated $24.7K and leaving 1,000 shares worth $216K. The position accounts for 0.02% of the portfolio, ranked #717.

Advyzon Investment Management first reported a position in BIIB in Q4 2025 and has held it in 3 quarters since. 1,038 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Advyzon Investment Management held 1,000 shares of Biogen worth $216K as of Q2 2026.
  • Advyzon Investment Management sold 129 Biogen shares in Q2 2026, an estimated $24.7K.
  • Biogen made up 0.02% of Advyzon Investment Management's portfolio in Q2 2026, its #717 holding.
  • Advyzon Investment Management first reported a position in Biogen in Q4 2025 and has held it in 3 quarters since.
  • 1,038 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Advyzon Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.